Neonatal lupus syndrome;Neonatal lupus-syndrom: Association til kongenit totalt atrioventrikulært blok

Ugeskrift for Laeger

Volumn 160, Issue 17, 1998, Pages 2521-2525

  Johansen, Anders S ^a   Herlin, Troels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA;

ARTIFICIAL HEART PACEMAKER; FEMALE; FETOMATERNAL TRANSFUSION; HEART BLOCK; HUMAN; IMMUNOLOGY; NEWBORN; PREGNANCY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; DNA; FEMALE; HEART BLOCK; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATERNAL-FETAL EXCHANGE; PACEMAKER, ARTIFICIAL; PREGNANCY;

EID: 0032549970     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Morquio L. Sur une maladie infantile et familiale caractérisée par des modifications permanentes du pouls, des attaques syncopales et epileptiformes et al. Mort subite. Arch Méd Enf 1901; 4: 467-75.
2. Aylward RD. Congenital heart block. BMJ 1928; 1: 943.
3. McCuistion CH, Schoch EP. Possible discoid lupus erythematosus in a newborn infant. Arch Dermatol 1954; 70: 782-5.
4. Lerner MB, Boyle JA, Hardin JA Steitz JA Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus Science 1981; 211: 400-2.
5. Gottlieb E, Steitz JA Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J 1989; 8: 851-61.
6. Boire G, Craft J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 1990; 83: 1182-90.
7. Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J. Peebles C et al. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr 1983; 103: 889-92.
8. Lee L, Norris DA Weston WL. Neonatal lupus and the pathogenesis of cutaneous lupus. Pediatr Dermatol 1986; 3: 491-7.
9. Silverman ED, Mamula M, Hardin JA, Laxer R. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol 1991; 18: 120-4.
10. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS. Prevalence of maternal Ro (SS-A) and (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol 1988; 27: 128-32.
11. Baboonian C, Venables PJW, Booth J, Williams DG, Roffe LM, Maini RN. Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol 1989; 78: 454-9.
12. Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D et al. Identification of mother at risk for congenital heart block and other neonatal syndromes in their children. Arthritis Rheum 1993; 36: 1263-73.
13. Buyon JP, Waltuck J, Caldwell K, Crawford B, Slade SG, Copel J et al. Relationship between maternal and neonatal levels of antibodies to 48 kDa SS-B (La), 52 kDa SS-A(Ro), and 60 kDa SS-A(Ro) in pregnancies complicated by congenital heart block. J. Rheumatol 1994; 21: 1943-50.
14. Julkunen H, Kurki P, Kaaja R, Heikkilä R, Immonen I, Chan EKL et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SSA/Ro and to SS-B/La. Arthritis Rheum 1983; 11: 1588-98.
15. Lawrence S, Domer T, Luy L, Hiepe F, Hamilton R, Laxer R et al. Maternal serology in the prediction of complete heart block (CHB) in neonatal lupus erythematosus (NLE). Arthritis Rheum 1996; 39: S189.
16. Barakat S, Meyer O, Torterotot F, Youinou P, Briand JP, Kahn MF et al IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein Clin Exp Immunol 1992; 89: 38-45.
17. McCune AB, Weston WL, Lee IA Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 1987; 106: 518-23.
18. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block Am J Med 1996; 100: 328-32.
19. Michaelson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972; 4: 85-101.
20. Pinsky WW, Gillette PC, Garson A, McNamara DG. Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 1982, 69: 728-33.
21. Lee LA, Bias WB, Arnett FC Jr, Huff JC, Norris DA, Harmon C et al. Immunogenetics of neonatal lupus syndrome. Ann Intern Med 1983; 99: 592-6.
22. Esscher E, Schott JS. Congenital heart block and maternal systemic lupus erythematosus. BMJ 1978; I: 1235-8.
23. Lockshin MD, Bonía E, Elkon K, Druzin ML. Neonatal lupus risk to newborns and mothers with systemic lupus erythematosus. Arthritis Rheum 1988; 31: 697-701.
24. Horsfall AC, Venables PJW, Taylor PV, Maini RN. Ro and La antigens and maternal autoantibody idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991; 4: 163-76.
25. Buyon JP, Winchester R. Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum 1990; 33: 609-14.
26. Herreman G, Galezewski N. Maternal connective tissue disease and congenital heart block [letter]. N Engl J Med 1985; 312: 1329.
27. Ho SY, Esscher E, Andersson RH, Michaelsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. AmJ Cardiol 1986; 58: 291-4
28. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977; 56: 82-9.
29. Alexander E, Buyon JP, Provost TT, Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model: in vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 1992; 35: 176-89.
30. Garcia S, Nascimento JHM, Bonfa E, Levy R, Oliviera SF, Tavares AV et al. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbits hearts. J Clin Invest 1994; 93: 718-24.
31. Deng JS, Sontheimer RD, Gilliam JN. Relationships between antinuclear and anti-Ro/SS-A antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol 1984; 11: 494-9.
32. Laxer RM, Roberts EA, Gross KR, Britton JR, Cuty E, Dimmick J et al. Liver disease in neonatal lupus erythematosus. J Pediatr 1990; 116: 238-42.
33. Silverman ED. Congenital heart block and neonatal lupus erythematosus: prevention is the goal. J Rheumatol 1993; 20: 1101-3.
34. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544-51.
35. Ross BA. Congenital complete atrioventricular block. Pediatr Clin North Am 1990; 37: 69-78.
36. McCredie M, Celermajer J, Sholler G, Kelly D, Chivers T, Wang Y et al. A case-control study of CHB: association with maternal antibodies to Ro (SS-A) and La (SS-B). BrJ Rheumatol 1990; 29: 10-4.
37. Buyon J, Roubey R, Swersky S, Pompeo L, Parker A, Baxi L et al. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol 1988; 15: 1104-8.
38. Rider LG, Buyon JP, Rutledge J, Sherry DD. Treatment of neonatal lupus: case report and review of the literature. J Rheumatol 1993; 20: 1208-11.
39. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol 1993; 20: 1204-7.